Pharmacokinetic Aspects During Continuous Ambulatory Peritoneal Dialysis: a Literature Review

Overview

Journal Pharm Weekbl Sci

Specialty Pharmacy

Date 1984 Dec 14

PMID 6393041

Citations 6

Authors

R Janknegt

C H Koks

Affiliations

Soon will be listed here.

Abstract

Since its introduction some years ago continuous ambulatory peritoneal dialysis (CAPD) has proved to be a valuable alternative to haemodialysis in the treatment of uraemia. Factors contributing to the transport of solutes through the peritoneal membrane are discussed and the literature concerning the pharmacokinetic aspects of CAPD is reviewed.

Citing Articles

Clinical pharmacokinetics during continuous ambulatory peritoneal dialysis.

Taylor 3rd C, Abdel-Rahman E, Zimmerman S, Johnson C Clin Pharmacokinet. 1996; 31(4):293-308.

PMID: 8896945 DOI: 10.2165/00003088-199631040-00005.

Toxicologic and pharmacokinetic evaluation of a case of vancomycin intoxication during continuous ambulatory peritoneal dialysis.

Hekster Y, Vree T, Weemaes C, Rotteveel J Pharm Weekbl Sci. 1986; 8(6):293-7.

PMID: 3808914 DOI: 10.1007/BF02280053.

Pharmacokinetics of cefradine, sulfamethoxazole and trimethoprim and their metabolites in a patient with peritonitis undergoing continuous ambulatory peritoneal dialysis.

Martea M, Hekster Y, Vree T, Voets A, Berden J Pharm Weekbl Sci. 1987; 9(2):110-6.

PMID: 3495778 DOI: 10.1007/BF01960745.

Drug therapy in continuous ambulatory peritoneal dialysis patients.

Janknegt R, Koelman J Pharm Weekbl Sci. 1987; 9(2):104-9.

PMID: 3295759 DOI: 10.1007/BF01960744.

Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Watson I, Stewart M, Platt D Clin Pharmacokinet. 1988; 15(3):133-64.

PMID: 3052984 DOI: 10.2165/00003088-198815030-00001.

References

Glasson P, Favre H . Treatment of peritonitis in continuous ambulatory peritoneal dialysis patients with co-trimoxazole. Nephron. 1984; 36(1):65-7. DOI: 10.1159/000183117. View

TWARDOWSKI Z, Ksiazek A, Majdan M, JANICKA L, Sokolowska G, GUTKA A . Kinetics of continuous ambulatory peritoneal dialysis (CAPD) with four exchanges per day. Clin Nephrol. 1981; 15(3):119-30. View

Thomae U, Boos W, Adam D . [Transperitoneal resorption of oxacillin, azlocillin and sisomicin in continuous ambulatory peritoneal dialysis in patients with and without peritonitis]. Med Welt. 1981; 32(37):1365-7. View

Kerr C, Perfect J, Craven P, Jorgensen J, Drutz D, Shelburne J . Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med. 1983; 99(3):334-6. DOI: 10.7326/0003-4819-99-3-334. View

MAHER J, HIRSZEL P, Abraham J, Galen M, Chamberlin M, Hohnadel D . The effect of dipyridamole on peritoneal mass transport. Trans Am Soc Artif Intern Organs. 1977; 23:219-24. DOI: 10.1097/00002480-197700230-00059. View

MAHER J, HIRSZEL P, Lasrich M . An experimental model for study of pharmacologic and hormonal influences on peritoneal dialysis. Contrib Nephrol. 1979; 17:131-8. DOI: 10.1159/000402988. View

De Paepe M, Belpaire F, Bogaerts Y . Pharmacokinetics of digoxin in C.A.P.D. Clin Exp Dial Apheresis. 1982; 6(1):65-73. DOI: 10.3109/08860228209050814. View

Hyneck M, Murphy J, Lipschutz D . Cimetidine clearance during intermittent and chronic peritoneal dialysis. Am J Hosp Pharm. 1981; 38(11):1760-2. View

Bunke C, Aronoff G, Brier M, SLOAN R, Luft F . Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther. 1983; 33(1):66-72. DOI: 10.1038/clpt.1983.9. View

10.

Vaziri N, Ness R, Barton C . Peritoneal dialysis clearance of cimetidine. Am J Gastroenterol. 1979; 71(6):572-6. View

11.

Rubin J, Rogers W, Taylor H, EVERETT E, Prowant B, Fruto L . Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med. 1980; 92(1):7-13. DOI: 10.7326/0003-4819-92-1-7. View

12.

Greaves W, Kreeft J, OGILVIE R, Richards G . Cefoxitin disposition during peritoneal dialysis. Antimicrob Agents Chemother. 1981; 19(2):253-5. PMC: 181403. DOI: 10.1128/AAC.19.2.253. View

13.

Chapman J, Warnock D . Ketoconazole and fungal CAPD peritonitis. Lancet. 1983; 2(8348):510-1. DOI: 10.1016/s0140-6736(83)90534-2. View

14.

Hess B, Keusch G, Fluckiger J, Binswanger U . [Pharmacokinetics of phenytoin in continuous ambulatory peritoneal dialysis. 2 cases and brief review of the literature]. Schweiz Med Wochenschr. 1984; 114(1):16-9. View

15.

Gross M, Somani P, Ribner B, Raeader R, FREIMER E, HIGGINS Jr J . Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther. 1983; 34(5):673-80. DOI: 10.1038/clpt.1983.231. View

16.

Khanna R, Oreopoulos D, Vas S, McCready W, Dombros N . Fungal peritonitis in patients undergoing chronic intermittent or continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc. 1980; 17:291-6. View

17.

Burgess E, Blair A . Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother. 1983; 24(2):237-9. PMC: 185144. DOI: 10.1128/AAC.24.2.237. View

18.

Pancorbo S, COMTY C . Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis. Nephron. 1982; 31(1):37-9. DOI: 10.1159/000182611. View

19.

Bunke C, Aronoff G, Brier M, SLOAN R, Luft F . Vancomycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther. 1983; 34(5):631-7. DOI: 10.1038/clpt.1983.225. View

20.

Nolph K, Twardowski Z, Popovich R, Rubin J . Equilibration of peritoneal dialysis solutions during long-dwell exchanges. J Lab Clin Med. 1979; 93(2):246-56. View